ddn, in collaboration with investment bank Mizuho SecuritiesUSA, is conducting a survey on the state of funding and views on cancerresearch, diagnosis and treatment. The goal of this survey is to gain a betterunderstanding of current and future trends in R&D activity.
Our web-based survey takes about four to five minutes tocomplete.
All information will remain confidential, and onlyaggregate, not individual responses nor company names, will be published.
In providing a response to this survey, you represent thatyou have not knowingly disclosed (i) any material nonpublic information; (ii)any trade secret or other proprietary information; (iii) information which youhave a duty or agreement to keep confidential; or (iv) information obtainedfrom any person expecting such information to be kept confidential or which youbelieve to be confidential.
Continue reading below...
InfographicsDiscovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Read MoreIfyou are interested in receiving a copy of the survey results, please indicatethat at the end of the survey.
Results will be published in ddn's May issue.
To view our previous surveys and results, visit the ddn Market Research page.
